Literature DB >> 19138372

The ontogenetic expression pattern of type 5 phosphodiesterase correlates with androgen receptor expression in rat corpora cavernosa.

Eleonora Carosa1, Simona Rossi, Nadia Giansante, Giovanni Luca Gravina, Alessandra Castri, Susanna Dolci, Flavia Botti, Annamaria Morelli, Luigi Di Luigi, Mario Pepe, Andrea Lenzi, Emmanuele A Jannini.   

Abstract

INTRODUCTION: The mechanisms controlling erection in animals and in humans are mainly age-dependent. However, the ontogenesis of the biochemical machinery of erection is largely unknown. AIM: The aim of this article was to study the expression pattern of androgen receptor (AR) and the major cyclic guanosine monophosphate-hydrolyzing enzyme present in the corpora cavernosa, type 5 phosphodiesterase (PDE5), in the rat penis during development.
METHODS: AR and PDE5 expression was tested on ribonucleic acids (RNAs) and proteins extracted from the whole penis or from primary cultures of smooth muscle cells obtained from the corpora cavernosa of 3- (rCC3), 20- (rCC20), and 60- (rCC60) day-old rats. Rat corpus cavernosum cells were characterized by immunocytochemistry and reverse transcriptase-polymerase chain reaction (RT-PCR). MAIN OUTCOME MEASURES: Expression of PDE5 and AR messenger RNA (mRNA) and protein have been measured by RT-PCR and Western blot, respectively.
RESULTS: A significant increase in PDE5 mRNA expression was observed with RT-PCR from prepuberty to adulthood (0.5 +/- 0.06 vs. 1.6 +/- 0.046 arbitrary units [a.u.]P = 0.049). This age-dependent increase was mirrored by the increase in PDE5 protein expression found when comparing neonatal to adult corpus cavernosum smooth muscle cells (1.5 +/- 0.26 vs. 4.9 +/- 0.59 a.u. P = 0.0038) and the further 1.6-fold increase from rCC20 to rCC60 (4.9 +/- 0.59 vs. 8.0 +/- 0.8 a.u. P = 0.0024). This is the first demonstration of the ontogenetic profile of PDE5 expression in corpus cavernosum smooth muscle. As it has been demonstrated that androgens control PDE5 expression and that PDE5 inhibitors need an optimal androgenic milieu to act perfectly on erection, the expression of AR protein in rat corpus cavernosum cells was then tested by Western blot. A 7.0-fold increase was observed in primary cultured cells from 3 to 60 days old (1.4 +/- 0.38 vs. 9.8 +/- 1.3 a.u. P = 0.0052).
CONCLUSION: The increase in ARs during rat penile development parallels that of PDE5 RNA and protein, thus suggesting a positive effect of androgens on PDE5 expression.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19138372     DOI: 10.1111/j.1743-6109.2008.01091.x

Source DB:  PubMed          Journal:  J Sex Med        ISSN: 1743-6095            Impact factor:   3.802


  5 in total

Review 1.  Translational Perspective on the Role of Testosterone in Sexual Function and Dysfunction.

Authors:  Carol A Podlasek; John Mulhall; Kelvin Davies; Christopher J Wingard; Johanna L Hannan; Trinity J Bivalacqua; Biljana Musicki; Mohit Khera; Nestor F González-Cadavid; Arthur L Burnett
Journal:  J Sex Med       Date:  2016-08       Impact factor: 3.802

Review 2.  The hormonal control of ejaculation.

Authors:  Giovanni Corona; Emmanuele A Jannini; Linda Vignozzi; Giulia Rastrelli; Mario Maggi
Journal:  Nat Rev Urol       Date:  2012-08-07       Impact factor: 14.432

3.  Ontogenetic profile of the expression of thyroid hormone receptors in rat and human corpora cavernosa of the penis.

Authors:  Eleonora Carosa; Stefania Di Sante; Simona Rossi; Alessandra Castri; Fabio D'Adamo; Giovanni Luca Gravina; Piero Ronchi; Zdenek Kostrouch; Susanna Dolci; Andrea Lenzi; Emmanuele A Jannini
Journal:  J Sex Med       Date:  2010-02-05       Impact factor: 3.802

Review 4.  Needs and Expectations of Patients with Erectile Dysfunction: An Update on Pharmacological Innovations in Phosphodiesterase Type 5 Inhibition with Focus on Sildenafil.

Authors:  Emmanuele A Jannini; Stéphane Droupy
Journal:  Sex Med       Date:  2018-12-03       Impact factor: 2.491

5.  Effects of testosterone treatment on clitoral haemodynamics in women with sexual dysfunction.

Authors:  S Cipriani; E Maseroli; V Di Stasi; I Scavello; T Todisco; G Rastrelli; M Fambrini; F Sorbi; F Petraglia; E A Jannini; M Maggi; L Vignozzi
Journal:  J Endocrinol Invest       Date:  2021-06-12       Impact factor: 4.256

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.